Immunotech Laboratories, Inc. announced that they have entered into negotiations with Uldic Investment Pvt. Ltd.

Immunotech Laboratories, Inc. (IMMB) announced that they have entered into negotiations with Uldic Investment Pvt. Ltd. , located in Zimbabwe, to pursue the development of market opportunities and Clinical Testing for the Company’s HIV/AIDS and Hepatitis C virus treatment (“ITV-1 Treatment”) in Africa, initially focusing on clinical testing for Hepatitis C in Mauritius Island and Malawi.